REAL-WORLD EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR/VOXILAPREVIR AS A HEPATITIS C VIRUS INFECTION SALVAGE TREATMENT

被引:0
|
作者
Krajden, Mel [1 ]
Cook, Darrel [2 ]
Wong, Stanley [2 ]
Wilton, James [2 ]
Butt, Zahid Ahmad [3 ]
Bartlett, Sofia [2 ]
Pearce, Margo [2 ]
Ramji, Alnoor [4 ]
Yoshida, Eric M. [5 ]
Yu, Amanda [2 ]
Alvarez, Maria Jose [2 ]
Binka, Mawuena [3 ]
Janjua, Naveed [2 ,6 ]
机构
[1] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC, Canada
[2] British Columbia Ctr Dis Control, Vancouver, BC, Canada
[3] Univ British Columbia, Vancouver, BC, Canada
[4] Univ British Columbia, Med, Vancouver, BC, Canada
[5] Univ British Columbia, Div Gastroenterol, Vancouver, BC, Canada
[6] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC, Canada
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
1519
引用
收藏
页码:914A / 914A
页数:1
相关论文
共 50 条
  • [1] Real-world effectiveness of sofosbuvir/velpatasvir/voxilaprevir as a hepatitis C virus infection salvage treatment
    Janjua, Naveed
    Wilton, James
    Cook, Darrel
    Wong, Stanley
    Butt, Zahid
    Bartlett, Sofia
    Pearce, Margo
    Ramji, Alnoor
    Yoshida, Eric
    Yu, Amanda
    Alvarez, Maria
    Binka, Mawuena
    Krajden, Mel
    JOURNAL OF HEPATOLOGY, 2020, 73 : S356 - S357
  • [2] Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in hepatitis C patients with prior failure to DAA treatment
    Graf, Christiana
    Degasperi, Elisabetta
    D'Ambrosio, Roberta
    Llaneras, Jordi
    Vermehren, Johannes
    Dultz, Georg
    Wetzstein, Nils
    Herrmann, Eva
    Zeuzem, Stefan
    Buti, Maria
    Lampertico, Pietro
    Dietz, Julia
    Sarrazin, Christoph
    JOURNAL OF HEPATOLOGY, 2023, 78 : S98 - S99
  • [3] EFFECTIVENESS OF SOFOSBUVIR / VELPATASVIR IN TREATING HEPATITIS C VIRUS INFECTION IN A REAL-WORLD SETTING
    Wilton, James
    Wong, Stanley
    Yu, Amanda
    Cook, Darrel
    Butt, Zahid Ahmad
    Alvarez, Maria Jose
    Binka, Mawuena
    Darvishian, Maryam
    Yoshida, Eric M.
    Ramji, Alnoor
    Krajden, Mel
    Janjua, Naveed
    HEPATOLOGY, 2019, 70 : 983A - 983A
  • [4] Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis
    Jing Xie
    Bin Xu
    Linlin Wei
    Chunyang Huang
    Wei Liu
    Infectious Diseases and Therapy, 2022, 11 : 1661 - 1682
  • [5] Effectiveness and Safety of Sofosbuvir/Velpatasvir/Voxilaprevir as a Hepatitis C Virus Infection Salvage Therapy in the Real World: A Systematic Review and Meta-analysis
    Xie, Jing
    Xu, Bin
    Wei, Linlin
    Huang, Chunyang
    Liu, Wei
    INFECTIOUS DISEASES AND THERAPY, 2022, 11 (04) : 1661 - 1682
  • [6] Real-world effectiveness of sofosbuvir/velpatasvir for the treatment of hepatitis C virus in prison settings
    Rosati, Silvia
    Wong, Alexander
    Di Marco, Vito
    Perez-Hernandez, Paco
    Macedo, Guilherme
    Brixko, Christian
    Ranieri, Roberto
    Campanale, Francesca
    Bascia, Annalisa
    Fernandez-Rodriguez, Conrado
    de Ledinghen, Victor
    Maida, Ivana
    Teti, Elisabetta
    Mangia, Alessandra
    Vanstraelen, Kim
    Hernandez, Candido
    Mertens, Michael
    Ntalla, Ioanna
    Ramroth, Heribert
    Jimenez, Elena
    FUTURE VIROLOGY, 2022, 17 (07) : 419 - 428
  • [7] Real-World Safety and Effectiveness of Sofosbuvir/Velpatasvir/Voxilaprevir and Glecaprevir/Pibrentasvir in Hepatitis C Infected Patients
    Saxena, Varun
    Chamberland, Scott
    Hurley, Leo
    Lai, Jennifer B.
    Truong, Elizabeth
    Marcus, Julia
    Champsi, Jamila
    Hare, Brad B.
    Korn, Daniel
    Ready, Joanna B.
    Seo, Suk
    Witt, David J.
    Silverberg, Michael J.
    HEPATOLOGY, 2018, 68 : 418A - 419A
  • [8] Sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection
    Kilaru, Saikiran M.
    Jacobson, Ira M.
    FUTURE VIROLOGY, 2019, 14 (02) : 61 - 71
  • [9] Real-world effectiveness of voxilaprevir/velpatasvir/sofosbuvir in patients following DAA failure
    Graf, Christiana
    D'Ambrosio, Roberta
    Degasperi, Elisabetta
    Paolucci, Stefania
    Llaneras, Jordi
    Vermehren, Johannes
    Dultz, Georg
    Peiffer, Kai-Henrik
    Finkelmeier, Fabian
    Herrmann, Eva
    Zeuzem, Stefan
    Buti, Maria
    Lampertico, Pietro
    Dietz, Julia
    Sarrazin, Christoph
    JHEP REPORTS, 2024, 6 (03)
  • [10] Sofosbuvir plus velpatasvir plus voxilaprevir for the treatment of hepatitis C infection
    Cory, Theodore J.
    Mu, Ying
    Gong, Yuqing
    Kodidela, Sunitha
    Kumar, Santosh
    EXPERT OPINION ON PHARMACOTHERAPY, 2018, 19 (07) : 749 - 757